These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10669174)

  • 1. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?
    Priori R; Conti F; Pittoni V; Garofalo T; Sorice M; Valesini G
    Thromb Haemost; 2000 Jan; 83(1):173-4. PubMed ID: 10669174
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J
    Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiannexin V autoantibody in thrombophilic Behçet's disease.
    Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
    Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies.
    Sorice M; Pittoni V; Griggi T; Losardo A; Leri O; Magno MS; Misasi R; Valesini G
    Clin Exp Immunol; 2000 May; 120(2):301-6. PubMed ID: 10792380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
    Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G
    J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
    Roubey RA
    Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of antiprotein-phospholipid antibodies.
    Carreras LO; Forastiero RR
    Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to beta2-glycoprotein I in anticardiolipin negative patients.
    Picillo U; Marcialis MR; Italiano G
    J Rheumatol; 1998 Jul; 25(7):1440-2. PubMed ID: 9676785
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome.
    Sorice M; Pittoni V; Circella A; Misasi R; Conti F; Longo A; Pontieri GM; Valesini G
    Thromb Haemost; 1998 Oct; 80(4):713-5. PubMed ID: 9799003
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.